Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2026-01-01 @ 10:53 AM
Study NCT ID:
NCT03993132
Status:
COMPLETED
Last Update Posted:
2024-02-12
First Post:
2019-06-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-16
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-19
First Submit QC Date:
None
Study First Post Date:
2019-06-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-15
Results First Submit QC Date:
None
Results First Post Date:
2024-02-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-15
Last Update Post Date:
2024-02-12
Last Update Post Date Type:
ACTUAL